FDA.reportPublic FDA data

nelarabine 375 MG per 75 ML Injection

RxCUI
2722411
RxNorm name
nelarabine 375 MG per 75 ML Injection
Display name
nelarabine 375 MG per 75 ML Injection
Full name
nelarabine 375 MG per 75 ML Injection
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:29

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
nelarabineNELARABINEShorla Oncology Inc.fc401b06-4e3b-413e-a854-3e031c4338622025-07-23Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 2722411

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
fc401b06-4e3b-413e-a854-3e031c433862nelarabine 375 MG in 75 ML Injection [PSN] · 75 ML nelarabine 5 MG/ML Injection [SCD] · nelarabine 375 MG per 75 ML Injection [SY]36These highlights do not include all the information needed to use NELARABINE INJECTION safely and effectively. See full prescribing information for NELARABINE INJECTION. NELARABINE injection, for intravenous use Initial U.S. Approval: 200520250723